Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTOR | P42345 | 19/20 | 0.37 |
| ▸ | PIK3CA | P42336 | 9/20 | 0.37 |
| ▸ | PIK3CG | P48736 | 6/20 | 0.37 |
| ▸ | PIK3CD | O00329 | 5/20 | 0.37 |
| ▸ | PIK3CB | P42338 | 5/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1708183 | 0.85 | FFAR1 (0.39) | MTORPIK3CAFFAR1 | |
| SCHEMBL1708704 | 0.81 | GAA (0.39) | MTORPIK3CAPIK3CGPIK3CDPIK3CB | |
| SCHEMBL13047337 | 0.79 | FFAR1 (0.37) | MTORPIK3CAPIK3CGPIK3CDPIK3CB | |
| SCHEMBL1708213 | 0.79 | MTOR (0.36) | MTORPIK3CAPIK3CGPIK3CDPIK3CB | |
| SCHEMBL1707916 | 0.79 | MTOR (0.36) | MTORPIK3CAPIK3CGPIK3CDPIK3CB | |
| SCHEMBL10010044 | 0.79 | PIK3CA (0.39) | MTORPIK3CAPIK3CG | |
| SCHEMBL10291211 | 0.79 | MTOR (0.34) | MTORPIK3CAPIK3CGPIK3CDPIK3CB | |
| SCHEMBL1707924 | 0.79 | FFAR1 (0.40) | FFAR1 | |
| SCHEMBL1708185 | 0.78 | ALDH1A1 (0.37) | MTORPIK3CAPIK3CGPIK3CDPIK3CB | |
| SCHEMBL1708215 | 0.77 | ALDH1A1 (0.36) | MTORPIK3CAPIK3CGPIK3CDPIK3CB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2440541-A1 | NOVEL FUSED CYCLIC COMPOUND AND USE THEREOF | Takeda Pharmaceutical Company Limited (JP) | 2012-04-18 | — | — | EP | disclosed |
| WO-2010143733-A1 | NOVEL FUSED CYCLIC COMPOUND AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-12-16 | — | — | WO | disclosed |